In vitro evidence for competitive tspo binding of the imaging biomarker candidates vinpocetine and two iodinated daa1106 analogues in post mortem autoradiography experiments on whole hemisphere human brain slices

Balázs Gulyás, Boglárka Makkai, Katalin Nagy, Ádám Vas, P. Kása, Jan Andersson, Tetsuya Suhara, Kazutoshi Suzuki, Makoto Higuchi, Zsuzsa Beliczai, K. Gulya, L. Csiba, Christer Halldin

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Earlier in vivo PET experiments have demonstrated the binding of the neuroprotective alkaloid vinpocetine to the peripheral benzodiazepine receptor (PBR) or, with other terminology, the TSPO (18kDa translocator protein). With the aim of demonstrating the direct binding of vinpocetine to TSPO in vitro, two different ionidated versions of the novel TSPO ligand DAA1106 were used in autoradiographic experiments on human postmortem whole hemisphere brain slices. Vinpocetine effectively blocked the binding of both [125I]desmethoxy-DAA1106 and [125I]desfluoro-DAA1106 to TSPO, the decrease in binding reaching 30 % to 64 % in various brain structures. This present findings yield further evidence to vinpocetine's direct binding to the TSPO in the human brain in vitro as well as to the possible use of its radiolabelled versions as imaging biomarkers. The results also support the usefulness of two ionidated versions of DAA1106 as biomarkers of TSPO for in vitro and in vivo studies in neurological diseases accompanied with microglia activation.

Original languageEnglish
Pages (from-to)42-48
Number of pages7
JournalCurrent Radiopharmaceuticals
Volume2
Issue number1
DOIs
Publication statusPublished - 2009

Fingerprint

vinpocetine
Competitive Binding
Autoradiography
Biomarkers
Brain
Proteins
Microglia
GABA-A Receptors
Alkaloids
Terminology
In Vitro Techniques
DAA 1106
Ligands

Keywords

  • Daa1106
  • Human brain
  • Imaging biomarker
  • Peripheral benzodiazepine receptor (pbr)
  • Radiopharmacon
  • Receptor binding
  • Tspo (18kda translocator protein)
  • Vinpocetine
  • Whole hemisphere autoradiography

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Pharmacology

Cite this

In vitro evidence for competitive tspo binding of the imaging biomarker candidates vinpocetine and two iodinated daa1106 analogues in post mortem autoradiography experiments on whole hemisphere human brain slices. / Gulyás, Balázs; Makkai, Boglárka; Nagy, Katalin; Vas, Ádám; Kása, P.; Andersson, Jan; Suhara, Tetsuya; Suzuki, Kazutoshi; Higuchi, Makoto; Beliczai, Zsuzsa; Gulya, K.; Csiba, L.; Halldin, Christer.

In: Current Radiopharmaceuticals, Vol. 2, No. 1, 2009, p. 42-48.

Research output: Contribution to journalArticle

Gulyás, Balázs ; Makkai, Boglárka ; Nagy, Katalin ; Vas, Ádám ; Kása, P. ; Andersson, Jan ; Suhara, Tetsuya ; Suzuki, Kazutoshi ; Higuchi, Makoto ; Beliczai, Zsuzsa ; Gulya, K. ; Csiba, L. ; Halldin, Christer. / In vitro evidence for competitive tspo binding of the imaging biomarker candidates vinpocetine and two iodinated daa1106 analogues in post mortem autoradiography experiments on whole hemisphere human brain slices. In: Current Radiopharmaceuticals. 2009 ; Vol. 2, No. 1. pp. 42-48.
@article{5629e7de9a484a4bb02ee5e3f29423d3,
title = "In vitro evidence for competitive tspo binding of the imaging biomarker candidates vinpocetine and two iodinated daa1106 analogues in post mortem autoradiography experiments on whole hemisphere human brain slices",
abstract = "Earlier in vivo PET experiments have demonstrated the binding of the neuroprotective alkaloid vinpocetine to the peripheral benzodiazepine receptor (PBR) or, with other terminology, the TSPO (18kDa translocator protein). With the aim of demonstrating the direct binding of vinpocetine to TSPO in vitro, two different ionidated versions of the novel TSPO ligand DAA1106 were used in autoradiographic experiments on human postmortem whole hemisphere brain slices. Vinpocetine effectively blocked the binding of both [125I]desmethoxy-DAA1106 and [125I]desfluoro-DAA1106 to TSPO, the decrease in binding reaching 30 {\%} to 64 {\%} in various brain structures. This present findings yield further evidence to vinpocetine's direct binding to the TSPO in the human brain in vitro as well as to the possible use of its radiolabelled versions as imaging biomarkers. The results also support the usefulness of two ionidated versions of DAA1106 as biomarkers of TSPO for in vitro and in vivo studies in neurological diseases accompanied with microglia activation.",
keywords = "Daa1106, Human brain, Imaging biomarker, Peripheral benzodiazepine receptor (pbr), Radiopharmacon, Receptor binding, Tspo (18kda translocator protein), Vinpocetine, Whole hemisphere autoradiography",
author = "Bal{\'a}zs Guly{\'a}s and Bogl{\'a}rka Makkai and Katalin Nagy and {\'A}d{\'a}m Vas and P. K{\'a}sa and Jan Andersson and Tetsuya Suhara and Kazutoshi Suzuki and Makoto Higuchi and Zsuzsa Beliczai and K. Gulya and L. Csiba and Christer Halldin",
year = "2009",
doi = "10.2174/1874471010902010042",
language = "English",
volume = "2",
pages = "42--48",
journal = "Current Radiopharmaceuticals",
issn = "1874-4710",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - In vitro evidence for competitive tspo binding of the imaging biomarker candidates vinpocetine and two iodinated daa1106 analogues in post mortem autoradiography experiments on whole hemisphere human brain slices

AU - Gulyás, Balázs

AU - Makkai, Boglárka

AU - Nagy, Katalin

AU - Vas, Ádám

AU - Kása, P.

AU - Andersson, Jan

AU - Suhara, Tetsuya

AU - Suzuki, Kazutoshi

AU - Higuchi, Makoto

AU - Beliczai, Zsuzsa

AU - Gulya, K.

AU - Csiba, L.

AU - Halldin, Christer

PY - 2009

Y1 - 2009

N2 - Earlier in vivo PET experiments have demonstrated the binding of the neuroprotective alkaloid vinpocetine to the peripheral benzodiazepine receptor (PBR) or, with other terminology, the TSPO (18kDa translocator protein). With the aim of demonstrating the direct binding of vinpocetine to TSPO in vitro, two different ionidated versions of the novel TSPO ligand DAA1106 were used in autoradiographic experiments on human postmortem whole hemisphere brain slices. Vinpocetine effectively blocked the binding of both [125I]desmethoxy-DAA1106 and [125I]desfluoro-DAA1106 to TSPO, the decrease in binding reaching 30 % to 64 % in various brain structures. This present findings yield further evidence to vinpocetine's direct binding to the TSPO in the human brain in vitro as well as to the possible use of its radiolabelled versions as imaging biomarkers. The results also support the usefulness of two ionidated versions of DAA1106 as biomarkers of TSPO for in vitro and in vivo studies in neurological diseases accompanied with microglia activation.

AB - Earlier in vivo PET experiments have demonstrated the binding of the neuroprotective alkaloid vinpocetine to the peripheral benzodiazepine receptor (PBR) or, with other terminology, the TSPO (18kDa translocator protein). With the aim of demonstrating the direct binding of vinpocetine to TSPO in vitro, two different ionidated versions of the novel TSPO ligand DAA1106 were used in autoradiographic experiments on human postmortem whole hemisphere brain slices. Vinpocetine effectively blocked the binding of both [125I]desmethoxy-DAA1106 and [125I]desfluoro-DAA1106 to TSPO, the decrease in binding reaching 30 % to 64 % in various brain structures. This present findings yield further evidence to vinpocetine's direct binding to the TSPO in the human brain in vitro as well as to the possible use of its radiolabelled versions as imaging biomarkers. The results also support the usefulness of two ionidated versions of DAA1106 as biomarkers of TSPO for in vitro and in vivo studies in neurological diseases accompanied with microglia activation.

KW - Daa1106

KW - Human brain

KW - Imaging biomarker

KW - Peripheral benzodiazepine receptor (pbr)

KW - Radiopharmacon

KW - Receptor binding

KW - Tspo (18kda translocator protein)

KW - Vinpocetine

KW - Whole hemisphere autoradiography

UR - http://www.scopus.com/inward/record.url?scp=77953800127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953800127&partnerID=8YFLogxK

U2 - 10.2174/1874471010902010042

DO - 10.2174/1874471010902010042

M3 - Article

AN - SCOPUS:77953800127

VL - 2

SP - 42

EP - 48

JO - Current Radiopharmaceuticals

JF - Current Radiopharmaceuticals

SN - 1874-4710

IS - 1

ER -